National Health Investors, Inc.

    Jurisdiction
    United States
    LEI
    549300ZPKZIG6DKDEC02
    ISIN
    US63633D1046 (NHI)
    Sectors
    1. Real Estate
    2. REIT - Healthcare Facilities

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €61.50 0.8% overvalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Incorporated in 1991, National Health Investors, Inc. Read full profile

    Fundamentals

    Net revenue
    €298.01M
    Gross margin
    87.8%
    EBIT
    €160.67M
    EBIT margin
    53.9%
    Net income
    €121.92M
    Net margin
    40.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €260.90M -12.5% €140.87M +15.5%
    €285.63M +9.5% €148.92M +5.7%
    €253.70M -11.2% €166.04M +11.5%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.92
    Ex date
    Payment date
    Dividend payout ratio
    113.0%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Earnings Calls

    Latest earnings call: May 7, 2024 (Q1 2024)

    Add to watchlist

    Notifications